TipRanks
Advertisement
Advertisement

AU:BLS Stock Latest News

Kirkman Trading Sells Down Stake in BLS Pharmaceuticals
Company AnnouncementsKirkman Trading Sells Down Stake in BLS Pharmaceuticals
7d ago
BLS
BLS Pharmaceuticals Sets AGM Date and Opens Director Nominations
PremiumCompany Announcements
BLS Pharmaceuticals Sets AGM Date and Opens Director Nominations
13d ago
BLS
BLS Pharmaceuticals Seeks ASX Quotation for 300,000 New Shares
PremiumCompany Announcements
BLS Pharmaceuticals Seeks ASX Quotation for 300,000 New Shares
15d ago
BLS
BLS Pharmaceuticals Seeks ASX Quotation for Additional Ordinary Shares
PremiumCompany Announcements
BLS Pharmaceuticals Seeks ASX Quotation for Additional Ordinary Shares
22d ago
BLS
Bioxyne Discloses New Director Appointment and Indirect Shareholdings
PremiumCompany Announcements
Bioxyne Discloses New Director Appointment and Indirect Shareholdings
1M ago
BLS
BLS Pharmaceuticals Names Angus Walker Alternate Director to Edward Myer
PremiumCompany AnnouncementsBLS Pharmaceuticals Names Angus Walker Alternate Director to Edward Myer
1M ago
BLS
BLS Pharmaceuticals Seeks ASX Quotation for Additional Ordinary Shares
Premium
Company Announcements
BLS Pharmaceuticals Seeks ASX Quotation for Additional Ordinary Shares
1M ago
BLS
S&P Dow Jones Sets September Rebalance for Key S&P/ASX Indices
Premium
Company Announcements
S&P Dow Jones Sets September Rebalance for Key S&P/ASX Indices
2M ago
BLS
BLS Pharmaceuticals Seeks ASX Quotation for Additional Shares
PremiumCompany Announcements
BLS Pharmaceuticals Seeks ASX Quotation for Additional Shares
2M ago
BLS
BLS Pharmaceuticals lodges ASX governance disclosures for FY2026
PremiumCompany Announcements
BLS Pharmaceuticals lodges ASX governance disclosures for FY2026
2M ago
BLS
BLS Pharmaceuticals lifts FY2027 guidance as global manufacturing footprint expands
PremiumCompany Announcements
BLS Pharmaceuticals lifts FY2027 guidance as global manufacturing footprint expands
2M ago
BLS
BLS Pharmaceuticals details FY2026 results under strict investor guidance
PremiumCompany Announcements
BLS Pharmaceuticals details FY2026 results under strict investor guidance
2M ago
BLS
BLS Pharmaceuticals Delivers Strong Profit Surge but Holds Back Dividends
PremiumCompany AnnouncementsBLS Pharmaceuticals Delivers Strong Profit Surge but Holds Back Dividends
2M ago
BLS
BLS Pharmaceuticals Sets FY2026 Results Release and Investor Webinar
Premium
Company Announcements
BLS Pharmaceuticals Sets FY2026 Results Release and Investor Webinar
2M ago
BLS
BLS Pharmaceuticals Seeks ASX Quotation for 326,779 New Shares
Premium
Company Announcements
BLS Pharmaceuticals Seeks ASX Quotation for 326,779 New Shares
2M ago
BLS
BLS Pharmaceuticals to Outline Growth Strategy at Coffee Microcaps Forum
PremiumCompany Announcements
BLS Pharmaceuticals to Outline Growth Strategy at Coffee Microcaps Forum
3M ago
BLS
BLS Pharmaceuticals Updates Investors Ahead of Q4 FY2026 Results Webinar
PremiumCompany Announcements
BLS Pharmaceuticals Updates Investors Ahead of Q4 FY2026 Results Webinar
3M ago
BLS
BLS Pharmaceuticals to Brief Investors on Q4 FY2026 Results in Upcoming Webinar
PremiumCompany Announcements
BLS Pharmaceuticals to Brief Investors on Q4 FY2026 Results in Upcoming Webinar
3M ago
BLS
BLS Pharmaceuticals to Commercialise Trexapharm’s TREXAVIVE Neurotherapy in Australia
PremiumCompany Announcements
BLS Pharmaceuticals to Commercialise Trexapharm’s TREXAVIVE Neurotherapy in Australia
3M ago
BLS
BLS Pharmaceuticals Expands Global Psychedelic Medicines Reach via Cayman Partnership
PremiumCompany AnnouncementsBLS Pharmaceuticals Expands Global Psychedelic Medicines Reach via Cayman Partnership
3M ago
BLS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >